Article

Proteomic Signatures of Neuropathological Alterations in Alzheimer’s Disease: Insights from the Bio-Hermes Study

2026-05-22

Abstract excerpt

Large-scale plasma proteomics can capture molecular changes across the Alzheimer’s disease (AD) continuum and provide insight into biological mechanisms associated with AD pathology. We analysed the Bio-Hermes cohort (n = 961), with participants enrolled across 17 sites in the United States from April 2021 to November 2022. Participants were stratified by clinical status and amyloid PET scan-based Core1 biomarker...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e838eebc-1682-547a-a5cb-eb81662c3f5e
DOI: 10.64898/2026.05.20.726478

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Proteomic Signatures of Neuropathological Alterations in Alzheimer’s Disease: Insights from the Bio-Hermes StudyDOI 10.64898/2026.05.20.726478Read

Proteomic Signatures of Neuropathological Alterations in Alzheimer’s Disease: Insights from the Bio-Hermes StudySemantic proximity Read

Multi-tissue proteomic signatures of Alzheimer’s disease: a systematic investigation in brain, CSF, blood and an exploratory study in tearsSemantic proximity Read

Alzheimer's Disease polygenic risk, the plasma proteome, and dementia incidence among UK older adults.Semantic proximity Read

Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer’s Disease related proteinsSemantic proximity Read

Novel Plasma Proteins Associated With Alzheimer’s Disease Risk in APOE ε4 Carriers and Non-carriersSemantic proximity Read

Single-subject Proteomic Signatures in Alzheimer’s Disease Reflect Clinical Phenotypes and Distinguish Asymptomatic from Symptomatic CasesSemantic proximity Read

Proteomic landscape of Alzheimer’s disease: emerging technologies, advances and insights (2021 – 2025)Semantic proximity Read

Identification of conserved proteomic networks in neurodegenerative dementiaSemantic proximity Read

Unified epigenomic, transcriptomic, proteomic, and metabolomic taxonomy of Alzheimer’s disease progression and heterogeneitySemantic proximity Read

Deep Plasma Proteomics Reveals Shared and Disease-Specific Molecular Signatures in Alzheimer’s Disease and Frontotemporal DementiaSemantic proximity Read

Longitudinal plasma proteomics separates diagnostic differences from progression-linked changes in Alzheimer’s diseaseSemantic proximity Read

Proteomic Subtyping of Alzheimer’s Disease CSF links Blood-Brain Barrier Dysfunction to Reduced levels of Tau and Synaptic BiomarkersSemantic proximity Read